Title of article :
Thyroid hormones homeostasis in pediatric patients during and after cardiopulmonary bypass
Author/Authors :
Bruno Murzi، نويسنده , , Giorgio Iervasi، نويسنده , , Silvano Masini، نويسنده , , Riccardo Moschetti، نويسنده , , Vittorio Vanini، نويسنده , , Gianfranco Zucchelli، نويسنده , , Andrea Biagini، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 1995
Abstract :
The concentrations of thyroid hormones were measured in 14 pediatric patients before, during, and after cardiopulmonary bypass. The ages of the patients ranged between 18 months and 14 years. Patients were kept normothermic, or moderate or deep hypothermia was induced depending on the specific pathologic condition involved. A marked reduction in the levels of total triiodothyronine, total thyroxine, free triiodothyronine, and thyroid-stimulating hormone, and in the ratio of free triiodothyronine to free thyroxine was detected during the time frame of the study. The minimum levels of each hormone were reached between 12 and 48 hours after cardiopulmonary bypass, indicating that changes in thyroid function and in the conversion of thyroxine to triiodothyronine are triggered by cardiopulmonary bypass and represent specific phenomena, and that these changes are progressively exacerbated during the postoperative period. The thyroid-stimulating hormone level was markedly reduced versus its baseline values (24% ± 0.13%), despite low levels of both total (40% ± 18%) and free (39% ± 20%) triiodothyronine: it returned to its preoperative level by the third postoperative day, but both the total (75% ± 10%) and free (74% ± 3%) triiodothyronine levels remained below their baseline values for 7 days postoperatively. Neither hemodilution nor hypothermia was responsible for the alteration observed. We conclude that pediatric patients undergoing cardiopulmonary bypass manifest changes in hormone metabolism similar to those seen in adult patients. These changes increase progressively during the postoperative period, and are still present 7 days postoperatively. The exact mechanism responsible for causing these changes is not thoroughly understood. Whether triiodothyronine replacement therapy is beneficial or deleterious remains controversial.
Journal title :
The Annals of Thoracic Surgery
Journal title :
The Annals of Thoracic Surgery